UnitedHealth Group shares climbed 7.3% over the past week as retail sentiment on social platforms shifted from deeply negative to neutral. Sentiment scores swung dramatically from 18 in November to a peak of 82 in December before settling at 42 out of 100 today. Discussions on Reddit’s major trading forums highlighted a recurring options trade story in which a deep in-the-money call position that lost nearly $3,000 when the stock dipped to $310 has since turned profitable. Institutional validation arrived when Berkshire Hathaway revealed a 5 million share stake, and options markets have remained active with long-dated call strategies. Technically, the share price has held support near both the 50-day and 200-day moving averages, signaling potential for further stabilization.

The Federal Trade Commission has granted a 14-day stay in its administrative proceeding against major pharmacy benefit managers, including UnitedHealth’s OptumRx unit. The pause delays the evidentiary hearing until July 1 and pushes back all discovery and filing deadlines. The original September 2024 complaint accused PBMs of using rebate structures and market power to inflate insulin prices. Recent staff reports also cited outsized markups on specialty generics. With political pressure intensifying and negotiations reportedly under way, the stay suggests regulators may be open to a settlement that could reshape OptumRx’s business practices.

At a House committee hearing, UnitedHealth CEO Stephen Hemsley pointed to rising hospital consolidation and drug costs as primary drivers of healthcare spending, rather than insurer profits. He announced that the company will voluntarily eliminate and rebate profits on its Affordable Care Act exchange plans for the current year, though financial impacts were not disclosed. Hemsley also detailed a pilot program accelerating Medicare Advantage payments to rural hospitals—aiming to cut collection times from under 30 days to 15—offering immediate cash-flow relief to facilities in states such as Oklahoma and Minnesota. He proposed policy reforms including site-neutral payment models, patent system changes and standardized broker compensation to promote affordability and transparency.